Related Experiment Video
Updated: May 9, 2026
07:51
High Throughput Microfluidic Rapid and Low Cost Prototyping Packaging Methods
Published on: December 23, 2013
Recent trends and future of pharmaceutical packaging technology
Nityanand Zadbuke1, Sadhana Shahi, Bhushan Gulecha
1Department of Pharmaceutics, Government College of Pharmacy, Aurangabad - 431005, Maharashtra, India.
Journal of Pharmacy & Bioallied Sciences
|July 9, 2013
Summary
The pharmaceutical packaging market, valued at over $20 billion, is driven by innovations in drug delivery and packaging technologies. Key trends include advanced vials, syringes, and anti-counterfeit measures, impacting industry growth and product protection.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
- Packaging Engineering
Background:
- The global pharmaceutical packaging market is experiencing significant growth, exceeding 5% annually and valued over $20 billion.
- Pharmaceuticals require packaging that ensures product protection, quality, tamper evidence, patient comfort, and security.
Purpose of the Study:
- To review recent trends in pharmaceutical packaging.
- To analyze the impact of pharmaceutical innovations on packaging requirements.
- To provide future predictions for the pharmaceutical packaging industry.
Main Methods:
- Literature review of recent advancements in pharmaceutical packaging.
- Analysis of emerging pharmaceutical product designs and their packaging implications.
- Synthesis of current market trends and expert predictions.
Main Results:
- Innovations such as blow fill seal (BFS) vials, anti-counterfeit technologies, and prefilled syringes are reshaping packaging demands.
- Plasma impulse chemical vapor deposition (PICVD) coating technology offers enhanced barrier properties.
- Unit dose vials, two-in-one prefilled vial designs, and child-resistant packs are gaining prominence.
Conclusions:
- Pharmaceutical packaging is directly influenced by advancements in drug formulation and delivery systems.
- The industry must adapt to new packaging technologies to meet evolving product and regulatory needs.
- Continued innovation in packaging is crucial for maintaining product integrity and patient safety.
Related Concept Videos
01:20Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:29Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...